ADVB
Advanced Biomed Inc. Common StockNASDAQHealthcare$4.55-2.86%ClosedMarket Cap: $4.9M
As of 2026-04-06
Valuation
P/E (TTM)
19.44
PEG
0.00
P/B
10.09
P/S
0.00
EV/EBITDA
-1.55
DCF Value
$141.41
FCF Yield
-73.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
100.8%
ROA
46.7%
ROIC
-17.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $0.00 | -Infinity% | $-396.6K | $6.9M | $0.31 | — |
| Q1 2026 | $0.00 | NaN% | $-523.9K | $-386.9K | $-0.02 | — |
| Q4 2025 | $0.00 | -Infinity% | $-39.3K | $-22.7K | $-0.02 | — |
| FY 2025 | $0.00 | NaN% | $0.00 | $0.00 | $-0.16 | — |
| Q3 2025 | $0.00 | NaN% | $-762.7K | $-1.4M | $-0.07 | — |
| Q2 2025 | $0.00 | NaN% | $-280.1K | $-907.9K | $-0.04 | — |
| Q1 2025 | $0.00 | NaN% | $-520.0K | $-265.6K | $-0.01 | — |
| Q4 2024 | $0.00 | NaN% | $-704.6K | $-809.4K | $0.00 | — |
| FY 2024 | $0.00 | NaN% | $-2.5M | $-2.8M | $-0.13 | — |
| Q3 2024 | $0.00 | NaN% | $-745.4K | $-1.1M | $-0.05 | — |
| Q2 2024 | $0.00 | NaN% | $-651.3K | $-145.3K | $-0.01 | — |
| Q1 2024 | $0.00 | NaN% | $-440.2K | $-771.3K | $-0.04 | — |